Position in NTRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$143,597
+$12,558 QoQ
Shares Held
529
-7.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#673
of 844 holders
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Aster Capital Management (DIFC) Ltd holds $5,791,116 across 10 Diagnostics & Research names. NTRA ranks #9 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,065 | $1,536,668 | |
| 2 | GH |
Guardant Health, Inc.
|
9,349 | $1,402,630 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
1,080 | $568,555 | |
| 4 | DGX |
Quest Diagnostics Inc
|
2,497 | $529,239 | |
| 5 | SHC |
Sotera Health Co
|
26,432 | $469,168 | |
| 6 | MTD |
Mettler Toledo International Inc/
|
344 | $439,463 | |
| 7 | MEDP |
Medpace Holdings, Inc.
|
614 | $325,168 | |
| 8 | ILMN |
Illumina, Inc.
|
1,806 | $317,548 |
All Filings in NTRA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $143,597 | 529 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $131,039 | 572 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $163,702 | 969 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $188,218 | 1,189 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||